| Product Code: ETC7552176 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Psoriatic Arthritis Treatment Market is experiencing growth driven by factors such as increasing prevalence of psoriatic arthritis, rising awareness about the condition, and advancements in treatment options. Biologic drugs, such as TNF inhibitors, IL-17 inhibitors, and IL-23 inhibitors, are commonly prescribed for managing psoriatic arthritis due to their efficacy in reducing inflammation and joint damage. Additionally, non-biologic disease-modifying antirheumatic drugs (DMARDs) and corticosteroids are also utilized in treatment regimens. The market is characterized by the presence of key players offering a range of treatment options, with a focus on research and development activities to introduce innovative therapies. Government initiatives to improve healthcare infrastructure and access to treatment, along with increasing healthcare expenditure, further contribute to the market growth in India.
The India Psoriatic Arthritis Treatment Market is witnessing a growing demand for advanced biologic therapies due to their efficacy in managing the symptoms of the disease. With increasing awareness about the condition and the availability of innovative treatment options, there is a significant opportunity for pharmaceutical companies to introduce new biologic drugs and targeted therapies in the market. Additionally, the adoption of telemedicine and digital healthcare platforms for remote consultations and monitoring of patients with psoriatic arthritis presents a promising avenue for healthcare providers to improve patient care and access to treatment. Collaborations between pharmaceutical companies and healthcare providers to develop personalized treatment plans tailored to individual patient needs are also emerging as a potential trend in the market.
The India Psoriatic Arthritis Treatment Market faces several challenges, including limited awareness among patients leading to underdiagnosis and undertreatment, high treatment costs making it inaccessible to many individuals, lack of specialized healthcare professionals with expertise in managing psoriatic arthritis, and limited availability of advanced treatment options. Additionally, the stigma associated with autoimmune diseases like psoriatic arthritis often leads to social barriers and delays in seeking appropriate medical care. The market also grapples with the need for increased research and development efforts to introduce more innovative and effective treatment solutions tailored to the specific needs of Indian patients. Addressing these challenges will be crucial in improving the overall management and outcomes of psoriatic arthritis in India.
The India Psoriatic Arthritis Treatment Market is primarily driven by the increasing prevalence of psoriatic arthritis in the country, coupled with growing awareness about the condition among healthcare professionals and patients. Additionally, advancements in treatment options, such as biologic therapies and targeted therapies, are fueling market growth by offering more effective and personalized treatment solutions. Moreover, the rising healthcare expenditure, improving access to healthcare services, and the presence of key market players investing in research and development activities are contributing to the expansion of the market. Furthermore, the emphasis on early diagnosis and treatment of psoriatic arthritis, along with the increasing adoption of combination therapies, is expected to drive the market further in the forecast period.
The Indian government has implemented various policies related to the treatment of Psoriatic Arthritis (PsA) in the country. These policies focus on improving access to healthcare services, promoting the development of affordable treatment options, and ensuring the availability of essential medications for PsA patients. The government has also introduced initiatives to raise awareness about PsA among healthcare professionals and the general public, in order to facilitate early diagnosis and timely treatment. Additionally, there is a push towards fostering research and development in the field of PsA treatment, with support for clinical trials and innovation in pharmaceuticals. Overall, the government policies aim to enhance the quality of care for PsA patients and address the growing burden of this condition in India.
The future outlook for the India Psoriatic Arthritis Treatment Market appears promising, driven by factors such as increasing awareness about the condition, rising healthcare expenditure, and advancements in treatment options. The market is expected to witness steady growth due to the growing prevalence of psoriatic arthritis in India and the expanding range of therapeutic options available to patients. Biologic drugs, targeted therapies, and improved diagnostic techniques are anticipated to drive market expansion. Additionally, collaborations between pharmaceutical companies and healthcare providers, as well as ongoing research and development activities, are likely to further propel market growth. Overall, the India Psoriatic Arthritis Treatment Market is poised for significant development in the coming years as the demand for effective treatment solutions continues to rise.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Psoriatic Arthritis Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Psoriatic Arthritis Treatment Market - Industry Life Cycle |
3.4 India Psoriatic Arthritis Treatment Market - Porter's Five Forces |
3.5 India Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 India Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 India Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 India Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Psoriatic Arthritis Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 India Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Psoriatic Arthritis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriatic arthritis in India |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas |
4.3.2 High cost of biologic therapies for psoriatic arthritis treatment |
4.3.3 Lack of reimbursement policies for expensive treatment options |
5 India Psoriatic Arthritis Treatment Market Trends |
6 India Psoriatic Arthritis Treatment Market, By Types |
6.1 India Psoriatic Arthritis Treatment Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2021- 2031F |
6.1.4 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Disease-modifying Antirheumatic Drugs (DMARDs), 2021- 2031F |
6.1.5 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Biologics, 2021- 2031F |
6.2 India Psoriatic Arthritis Treatment Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Oligoarticular, 2021- 2031F |
6.2.3 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Polyarticular, 2021- 2031F |
6.3 India Psoriatic Arthritis Treatment Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Therapy, 2021- 2031F |
6.3.3 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.4 India Psoriatic Arthritis Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5 India Psoriatic Arthritis Treatment Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 India Psoriatic Arthritis Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 India Psoriatic Arthritis Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Psoriatic Arthritis Treatment Market Import-Export Trade Statistics |
7.1 India Psoriatic Arthritis Treatment Market Export to Major Countries |
7.2 India Psoriatic Arthritis Treatment Market Imports from Major Countries |
8 India Psoriatic Arthritis Treatment Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for psoriatic arthritis patients |
8.2 Number of healthcare facilities offering specialized treatment for psoriatic arthritis |
8.3 Patient adherence rate to prescribed treatment regimens |
8.4 Percentage of psoriatic arthritis patients achieving disease remission with treatment |
8.5 Number of ongoing clinical trials for new psoriatic arthritis treatments in India |
9 India Psoriatic Arthritis Treatment Market - Opportunity Assessment |
9.1 India Psoriatic Arthritis Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 India Psoriatic Arthritis Treatment Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 India Psoriatic Arthritis Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 India Psoriatic Arthritis Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Psoriatic Arthritis Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 India Psoriatic Arthritis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Psoriatic Arthritis Treatment Market - Competitive Landscape |
10.1 India Psoriatic Arthritis Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Psoriatic Arthritis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |